FDA Authorizes Use of New Device to Treat Esophageal Birth Defect in Babies

May 12, 2017 -- The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their...

http://ift.tt/2qjJaRk